Pulmonary Tuberculosis and Drug Resistance in Dhaka Central Jail, the Largest Prison in Bangladesh
Overview
Authors
Affiliations
Background: There are limited data on TB among prison inmates in Bangladesh. The aim of the study was to determine the prevalence of pulmonary tuberculosis (TB), its drug resistance and risk factors in Dhaka Central Jail, the largest prison in Bangladesh.
Methods: Cross sectional survey with, active screening of a total number of 11,001 inmates over a period of 2 years. Sputum samples from TB suspects were taken for acid- fast bacilli (AFB) microscopy, culture and drug susceptibility testing.
Results: Among 1,781 TB suspects 245 (13.8%) were positive for AFB on microscopy and/or culture. The prevalence rate of sputum- positive pulmonary TB was 2,227/100,000. Fifty three cases (21.6% of 245 cases) were AFB- negative on microscopy but were found positive on culture. Resistance to isoniazid, rifampicin, streptomycin and ethambutol was 11.4%, 0.8%, 22.4% and 6.5% respectively. No multidrug resistance was observed. The main risk factors of TB in prison were exposure to TB patients (adjusted odds ratio 3.16, 95% CI 2.36-4.21), previous imprisonment (1.86, 1.38-2.50), longer duration of stay in prison (17.5 months for TB cases; 1.004, 1.001-1.006) and low body mass index which is less than 18.5 kg/m(2) (5.37, 4.02-7.16).
Conclusions: The study results revealed a very high prevalence of TB in the prison population in Dhaka Central Jail. Entry examinations and active symptom screening among inmates are important to control TB transmission inside the prison. Identifying undiagnosed smear-negative TB cases remains a challenge to combat this deadly disease in this difficult setting.
Yield of TB screening in prisons in Tajikistan.
Moe S, Asozoda M, Aung A, Dusmatova Z, Akintore F, Nshimiyimana E IJTLD Open. 2024; 1(8):344-348.
PMID: 39131592 PMC: 11308400. DOI: 10.5588/ijtldopen.24.0272.
Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB.
Placeres A, de Almeida Soares D, Delpino F, Moura H, Scholze A, Santos M BMC Infect Dis. 2023; 23(1):20.
PMID: 36631770 PMC: 9835258. DOI: 10.1186/s12879-022-07961-8.
Hoog A, Viney K, Biermann O, Yang B, Leeflang M, Langendam M Cochrane Database Syst Rev. 2022; 3:CD010890.
PMID: 35320584 PMC: 9109771. DOI: 10.1002/14651858.CD010890.pub2.
Spatial distribution of TB among individuals with a history of incarceration.
Robsky K, Mukiibi J, Nalutaaya A, Kitonsa P, Isooba D, Nakasolya O Int J Tuberc Lung Dis. 2021; 25(6):513-515.
PMID: 34049618 PMC: 8730719. DOI: 10.5588/ijtld.21.0065.
Kundu S, Marzan M, Gan S, Islam M Antibiotics (Basel). 2020; 9(10).
PMID: 33080862 PMC: 7602942. DOI: 10.3390/antibiotics9100710.